[Lymphadenopathies and protein anomalies following phenylhydantoine therapy].
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D001796:Blood Protein Disorders / Q000139:chemically induced* / Q000276:immunology; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects*; D007074:Immunoglobulin G / Q000032:analysis; D008206:Lymphatic Diseases / Q000139:chemically induced* / Q000145:classification / Q000276:immunology; D008219:Lymphogranuloma Venereum / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced
D000888:Antibodies, Anti-Idiotypic; D006827:Hydantoins; D007074:Immunoglobulin G
Lymphadénopathie et anomalies protidiques après traitement par la phénylhydantoïne